In vitro, AFP has been proven to have an oncogenic effect by regulating TNF cytotoxicity [181], suppressing NK cell activity, [182] and promoting tumor growth by reducing levels of FAS-associated death domain protein (FADD) [183]. This evidence concerns the gene FADD and neoplasm.